Acute Coronary Syndromes

Antiplatelet Therapy: Point-of-Care Testing 101

Jul 21, 2010 09:53 EDT

Drs. Storey, Kereiakes, and Montalescot discuss the use of point-of-care testing to assess antiplatelet responsiveness, including strategies for treating poor responders.

Managing Risk in the Post-PCI Patient

Jul 15, 2010 09:23 EDT

It is becoming clear that dual antiplatelet therapy may need frequent reevaluation and monitoring in patients following an acute coronary syndrome (ACS). Join Drs. Peter P. Toth and Christopher P. Cannon who will address a number of challenging decision points that can occur in the long-term management of these patients.

Acute Coronary Syndromes

Minimizing the Risk for Stent Thrombosis

2 COMMENTS - Jul 8, 2010 13:37 EDT

Dr. Gershlick quizzes Dr. Collet regarding his stent-thrombosis prevention strategies and his thoughts on trials such as GRAVITAS and DAPT.

Acute Coronary Syndromes

Tailoring Oral Antiplatelet Therapy in ACS Patients Undergoing PCI

Jul 8, 2010 12:57 EDT

POPULAR PI Dr. ten Berg discusses the practicalities of using genetics and platelet-response assays to optimize antiplatelet therapy.

Acute Coronary Syndromes

Managing Acute Coronary Syndrome in Primary Care

Jun 29, 2010 13:41 EDT

This webcast will feature a case-based approach to discuss individualized antiplatelet therapy in a high-risk patient with ST-segment-elevation myocardial infarction.

Acute Coronary Syndromes

The Late Night Report - Part 1

1 COMMENT - Jun 22, 2010 11:04 EDT

What dictates choice of antiplatelet therapy? What are the predictors of cardiac events in medically managed patients with ACS? Drs. Ohman, Cohen, and Mehran discuss these important questions based on recent data in the "Late Night Report."

Acute Coronary Syndromes

Individualized Antiplatelet Therapy in Acute Coronary Syndrome: Evidence-Based Perspectives

Jun 17, 2010 10:39 EDT

A case-based approach will be used to highlight the latest developments in the individualized initial and long-term management of patients with acute coronary syndrome (ACS) to optimize patient outcomes in the cardiology setting.

Acute Coronary Syndromes

Challenges and Strategies in the Management of Anticoagulant and Antiplatelet Therapy in Cardiac Surgery

1 COMMENT - Jun 1, 2010 13:40 EDT

Join Drs. Mack, Bridges, Kappetein, and Taggart for a discussion on managing anticoagulant and antiplatelet therapy in cardiac surgery.

Acute Coronary Syndromes

The Clinical Syndromes of Arterial Thrombosis

2 COMMENTS - May 28, 2010 11:39 EDT

Join Drs. Harrington, Turpie, and Singer for a discussion on novel antiplatelet and anticoagulant therapy in acute coronary syndromes and atrial fibrillation.

Acute Coronary Syndromes

Managing Atherothrombosis With Antiplatelet Therapy: Challenges and Opportunities

May 14, 2010 11:01 EDT

Explore emerging evidence of new antiplatelet therapies as well as hot topics with current antiplatelet drugs.

Acute Coronary Syndromes

Assessing the Costs of Antiplatelet Resistance

May 7, 2010 13:44 EDT

Are more potent P2Y₁₂ inhibitors cost-effective compared with clopidogrel? Dr. Bates leads a discussion with Drs. Mahoney and Weintraub.

Acute Coronary Syndromes

Antiplatelet Therapy: What's New?

1 COMMENT - Apr 30, 2010 12:14 EDT

CILON-T, PLATO, and the black-box warning for clopidogrel are among the issues discussed by Drs. Bhatt, Mahaffey, and Price.

Interventional/Surgery

DES and Dual Antiplatelet Therapy: Current and Future Perspectives

Apr 20, 2010 10:00 EDT

What is the optimal duration of dual antiplatelet therapy in patients with DES? Drs. Kandzari, Mauri, and Rao discuss data from the ACC conference and the ongoing DAPT study.

Acute Coronary Syndromes

Testing the Trialists -- Part I

Mar 31, 2010 14:22 EDT

How do we treat poor clopidogrel responders? Routine invasive strategy reduces CV outcomes, but what is the best strategy for medically managed patients? Join Drs. Ohman, Topol, and Fox as they discuss these controversial issues in "Testing the Trialists."

Acute Coronary Syndromes

Differentiating Antiplatelet Therapy in ACS

2 COMMENTS - Mar 30, 2010 14:18 EDT

Join our international panel of experts, Drs. Bhatt, Cannon, Gurbel, and Storey, as they discuss new data on antiplatelet therapies for patients with ACS.

Acute Coronary Syndromes

Update on Novel Antiplatelet and Anticoagulant Agents: A Clinical Perspective for Best Practices

6 COMMENTS - Mar 26, 2010 10:02 EDT

Join Dr. John Alexander for an interactive clinical update on novel antiplatelet and anticoagulant therapy in acute coronary syndromes and atrial fibrillation.

Acute Coronary Syndromes

Focus on Antiplatelet Therapy at AHA 2009

1 COMMENT - Feb 12, 2010 14:07 EST

CHAMPION, PLATO, and OPTIMUS were among the trials featured at AHA. Read Dr. Prasad's review and watch presentations by Drs. Angiolillo, Gurbel, Harrington, and Storey.

Acute Coronary Syndromes

The Key to Their Hearts: The Indispensable Role of the Primary Care Clinician in the Management of Patients Post-MI

Feb 12, 2010 10:16 EST

Drs. Toth and McPherson discuss the importance of collaboration between PCPs and cardiologists in managing patients with ACS to decrease adverse outcomes and mortality. They review the ACC/AHA guidelines for appropriate length of therapy, risk-factor reduction, and medication use before and after interventions.

Acute Coronary Syndromes

Best Practices in STEMI Management: The Crossroads of Bleeding and Outcomes

Feb 3, 2010 10:49 EST

Dr. Steg introduces a discussion between Drs. Gershlick and Hamon on achieving a balance between favorable outcomes and reducing bleeding in STEMI patients.

Acute Coronary Syndromes

Antiplatelets in PCI: Doses and Choices

3 COMMENTS - Jan 21, 2010 13:36 EST

Recent data on aspirin and clopidogrel dosing in PCI have left many confused. Dr. Ohman navigates through the data with Drs. Gurbel and Storey.

Acute Coronary Syndromes

Antiplatelet Therapy for Atherothrombotic Disease: Taking the Next Steps

1 COMMENT - Jan 4, 2010 14:37 EST

Examine current perspectives in antiplatelet therapy on emerging agents vs current therapy, and review data from recently completed clinical trials.

Acute Coronary Syndromes

Stent Thrombosis: A Case-Based Discussion

Dec 17, 2009 14:59 EST

Dr. Holmvang presents 2 cases of stent thrombosis to Dr. Kristensen outlining risk factors and potential strategies to prevent this catastrophic event.

Acute Coronary Syndromes

Antiplatelet Therapy in ACS: Copenhagen Masterclass Roundtable

3 COMMENTS - Dec 16, 2009 16:10 EST

What are the implications of recent data on the antiplatelet agents in ACS for Europe? Recorded at the 2009 ACS Masterclass in Copenhagen, Denmark, Dr. Clemmensen leads a roundtable discussion with Drs. Collet, Kristensen, and Schühlen.

Acute Coronary Syndromes

Thrombosis: Describing the Clinical Link Between the Coagulation Cascade and Platelet Function

5 COMMENTS - Dec 14, 2009 17:21 EST

Join Drs. Alexander, Becker, and Weitz for a discussion on the coagulation cascade, its link to platelet function, and the risk/benefit and clinical utility of agents that target the coagulation cascade and platelet receptors.

Acute Coronary Syndromes

Translating Evidence From Trials With Antiplatelet Agents Into Clinical Practice

Dec 8, 2009 10:03 EST

Recently reported and new trials of antiplatelet therapy continue to redefine optimal management strategies for patients with atherothrombotic disease and patients with atrial fibrillation. Drs. Harrington, Angiolillo, Bhatt, Connolly, Mehta, and Simon discuss guidelines? recommendations for the use of antiplatelet therapies and the potential impact of emerging data regarding currently used and novel antiplatelet agents.